Cargando…

Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases

BACKGROUND: Nephrotic syndrome (NS) is associated with increased risk of thromboembolic events (TE) adding to the morbidity and mortality. International guidelines recommend prophylactic anticoagulation in patients with NS and high risk of TE, but no studies have identified the optimal type of antic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelddal, Sarah, Hvas, Anne-Mette, Grove, Erik Lerkevang, Birn, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446569/ https://www.ncbi.nlm.nih.gov/pubmed/36064370 http://dx.doi.org/10.1186/s12882-022-02929-x

Ejemplares similares

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Efficacy and Safety of Oral Anticoagulants in Patients with Systolic Heart Failure in Sinus Rhythm: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Cohort Studies
por: Nygaard, Marie H., et al.
Publicado: (2020)

A 19-Year-Old Man with a History of Recreational Inhalation of Nitrous Oxide with Severe Peripheral Neuropathy and Central Pulmonary Embolism
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis
por: Hellfritzsch, Maja, et al.
Publicado: (2019)

Platelet Turnover in Stable Coronary Artery Disease – Influence of Thrombopoietin and Low-Grade Inflammation
por: Larsen, Sanne Bøjet, et al.
Publicado: (2014)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
por: Ording, Anne Gulbech, et al.
Publicado: (2021)

Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Genetic Determinants of On-Aspirin Platelet Reactivity: Focus on the Influence of PEAR1
por: Würtz, Morten, et al.
Publicado: (2014)

Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover
por: Pedersen, Oliver Heidmann, et al.
Publicado: (2017)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction
por: Maag, Emil, et al.
Publicado: (2021)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin
por: Neergaard-Petersen, Søs, et al.
Publicado: (2015)

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2017)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2022)

Haemostasis and fibrinolysis after regular high-intensity interval training in patients with coronary artery disease: a randomised controlled trial
por: Kristiansen, Jacobina, et al.
Publicado: (2022)

Advanced Flow Cytometry Using the SYTO-13 Dye for the Assessment of Platelet Reactivity and Maturity in Whole Blood
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2023)

Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial
por: Kristiansen, Jacobina, et al.
Publicado: (2022)

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
por: Neergaard-Petersen, Søs, et al.
Publicado: (2013)

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation
por: Hellfritzsch, Maja, et al.
Publicado: (2017)

Coronary artery disease-associated genetic variants and biomarkers of inflammation
por: Christiansen, Morten Krogh, et al.
Publicado: (2017)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Sex Differences in Treatment Quality of Self-Managed Oral Anticoagulant Therapy: 6,900 Patient-Years of Follow-Up
por: Nilsson, Hanna, et al.
Publicado: (2014)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Ventricular Tachycardia Induced by Weight Loss Pills
por: Pareek, Manan, et al.
Publicado: (2013)

Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome—A retrospective observational study
por: Welander, Frida, et al.
Publicado: (2021)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Direct mail improves knowledge of basic life support guidelines in general practice: a randomised study
por: Secher, Niels, et al.
Publicado: (2012)

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
por: Shovlin, C. L., et al.
Publicado: (2019)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Vaccines and nephrotic syndrome: efficacy and safety
por: Angeletti, Andrea, et al.
Publicado: (2022)

Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia
por: Hellfritzsch, Maja, et al.
Publicado: (2015)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome
por: Okada, Mari, et al.
Publicado: (2017)

Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
por: Ghazvinian, R., et al.
Publicado: (2018)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sha961reg4sa9hta2m0hn9rel5